Danish biotech Genmab hit by ending of trial using key cancer drug - Nano News Online

Monday, May 28, 2018

Danish biotech Genmab hit by ending of trial using key cancer drug

COPENHAGEN (Reuters) - Shares in Danish biotech Genmab fell by as much as 25 percent on Monday after its partner Johnson & Johnson decided to ditch a study using its blockbuster cancer drug.


from Reuters: Health News https://ift.tt/2ku08Zf

No comments:

Post a Comment